Somnogen

Somnogen Canada Inc is a Canadian multinational pharmaceutical corporation headquartered in Toronto. It develops and markets a range of prescription and OTC medications for sleep disorders, including insomnia and excessive daytime sleepiness. Its portfolio includes both single-agent drugs like zolpidem, doxepin, lorazepam, clonazepam, alprazolam, cetirizine, diphenhydramine as well as combination therapies targeting comorbid psychiatric or neurological symptoms. The company does not own manufacturing facilities but relies on contract manufacturing partners. No recent clinical trial results are reported; the focus is on commercialized products for established indications in sleep medicine